Teva Pharmaceutical Industries Ltd. ADR-0.62% $20.28B ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Last week's rumour that GSK was poised to make a bid to acquire IDRx and its experimental targeted therapy for a rare form of rare gastrointestinal cancer was on the money. This morning ...

When it comes to ice cream, most of us can agree on one thing: quality makes all the difference. Sure, a frozen tub of sugary slush from the corner store might do in a pinch, but when you want ice ...

incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 33,210.36 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Products are independently selected by our editors. We may earn an affiliate commission from links.

January 13, 2025--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based ...

(Alliance News) - GSK PLC on Tuesday said applications for its treatment for a type of asthma and chronic rhinosinusitis with nasal polyps, or CRSwNP, have been accepted for review in China, Japan and ...

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work with the University of Oxford on a cancer vaccine research program.